Integrative analysis of breast cancer profiles in TCGA by TNBC subgrouping reveals novel microRNA-specific clusters, including miR-17-92a, distinguishing basal-like 1 and basal-like 2 TNBC subtypes
Published 2020 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Integrative analysis of breast cancer profiles in TCGA by TNBC subgrouping reveals novel microRNA-specific clusters, including miR-17-92a, distinguishing basal-like 1 and basal-like 2 TNBC subtypes
Authors
Keywords
-
Journal
BMC CANCER
Volume 20, Issue 1, Pages -
Publisher
Springer Science and Business Media LLC
Online
2020-02-21
DOI
10.1186/s12885-020-6600-6
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Genomic and Transcriptomic Landscape of Triple-Negative Breast Cancers: Subtypes and Treatment Strategies
- (2019) Yi-Zhou Jiang et al. CANCER CELL
- Refinement of breast cancer molecular classification by miRNA expression profiles
- (2019) Rolf Søkilde et al. BMC GENOMICS
- MetaboAnalyst 4.0: towards more transparent and integrative metabolomics analysis
- (2018) Jasmine Chong et al. NUCLEIC ACIDS RESEARCH
- MicroRNA therapeutics: towards a new era for the management of cancer and other diseases
- (2017) Rajesha Rupaimoole et al. NATURE REVIEWS DRUG DISCOVERY
- Dissecting the biological relationship between TCGA miRNA and mRNA sequencing data using MMiRNA-Viewer
- (2016) Yongsheng Bai et al. BMC BIOINFORMATICS
- Toward a Shared Vision for Cancer Genomic Data
- (2016) Robert L. Grossman et al. NEW ENGLAND JOURNAL OF MEDICINE
- MiRComb: An R Package to Analyse miRNA-mRNA Interactions. Examples across Five Digestive Cancers
- (2016) Maria Vila-Casadesús et al. PLoS One
- miTALOS v2: Analyzing Tissue Specific microRNA Function
- (2016) Martin Preusse et al. PLoS One
- Refinement of Triple-Negative Breast Cancer Molecular Subtypes: Implications for Neoadjuvant Chemotherapy Selection
- (2016) Brian D. Lehmann et al. PLoS One
- microRNAs in breast cancer: regulatory roles governing the hallmarks of cancer
- (2015) Jen N. Goh et al. BIOLOGICAL REVIEWS
- The miR-17-92 cluster counteracts quiescence and chemoresistance in a distinct subpopulation of pancreatic cancer stem cells
- (2015) Michele Cioffi et al. GUT
- DIANA-miRPath v3.0: deciphering microRNA function with experimental support
- (2015) Ioannis S. Vlachos et al. NUCLEIC ACIDS RESEARCH
- MicroRNA-based therapy and breast cancer: A comprehensive review of novel therapeutic strategies from diagnosis to treatment
- (2015) Parham Jabbarzadeh Kaboli et al. PHARMACOLOGICAL RESEARCH
- Predicting effective microRNA target sites in mammalian mRNAs
- (2015) Vikram Agarwal et al. eLife
- MicroRNA-20b promotes cell growth of breast cancer cells partly via targeting phosphatase and tensin homologue (PTEN)
- (2014) Weidong Zhou et al. Cell and Bioscience
- A survey of immunohistochemical biomarkers for basal-like breast cancer against a gene expression profile gold standard
- (2013) Jennifer R Won et al. MODERN PATHOLOGY
- DIANA-microT web server v5.0: service integration into miRNA functional analysis workflows
- (2013) Maria D. Paraskevopoulou et al. NUCLEIC ACIDS RESEARCH
- Comprehensive molecular portraits of human breast tumours
- (2012) Daniel C. Koboldt et al. NATURE
- Identification of human triple-negative breast cancer subtypes and preclinical models for selection of targeted therapies
- (2011) Brian D. Lehmann et al. JOURNAL OF CLINICAL INVESTIGATION
- Triple-Negative Breast Cancer
- (2010) William D. Foulkes et al. NEW ENGLAND JOURNAL OF MEDICINE
- Inositol polyphosphate 4-phosphatase II regulates PI3K/Akt signaling and is lost in human basal-like breast cancers
- (2010) C. G. Fedele et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- An online survival analysis tool to rapidly assess the effect of 22,277 genes on breast cancer prognosis using microarray data of 1,809 patients
- (2009) Balazs Györffy et al. BREAST CANCER RESEARCH AND TREATMENT
- Evidence that Inositol Polyphosphate 4-Phosphatase Type II Is a Tumor Suppressor that Inhibits PI3K Signaling
- (2009) Christina Gewinner et al. CANCER CELL
- Response to Neoadjuvant Therapy and Long-Term Survival in Patients With Triple-Negative Breast Cancer
- (2008) Cornelia Liedtke et al. JOURNAL OF CLINICAL ONCOLOGY
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now